Global  

Biogen resurrects Alzheimer's drug, stock soars

Video Credit: Rumble - Duration: 00:59s - Published
Biogen resurrects Alzheimer's drug, stock soars

Biogen resurrects Alzheimer's drug, stock soars

Shares of Biogen skyrocketed roughly 40 percent Tuesday after the biotech company said it will seek approval for an Alzheimer's treatment after abandoning the drug earlier this year.

Freddie Joyner has the story.


You Might Like


Tweets about this


Related videos from verified sources

Jim Cramer's Thoughts on Biogen's Alzheimer's Drug [Video]

Jim Cramer's Thoughts on Biogen's Alzheimer's Drug

Shares of Biogen were up close to 40% this morning after the company said it plans to pursue regulatory approval for aducanumab, a drug for early Alzheimer's disease. The stock has come down a bit..

Credit: The Street     Duration: 00:48Published